Document is current

Any future updates will be listed below

The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy

Crossref DOI link: https://doi.org/10.1186/s40644-014-0034-9

Published Online: 2014-11-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark